Metabolic monitoring for atypical antipsychotics
Note:  more comprehensive or frequent monitoring may be needed if chronic medical conditions exist
[select name="Q1" value="Baseline|6 weeks after starting drug treatment|12 weeks after starting drug treatment|Annual"] <-- Interval
[conditional field="Q1" condition="(Q1).is('Baseline')||(Q1).is('Annual')"]Medical history
Blood pressure
Body mass index
Waist circumference
Fasting glucose level
Fasting lipid levels
Lifestyle counseling[/conditional][conditional field="Q1" condition="(Q1).is('6 weeks after starting drug treatment')||(Q1).is('12 weeks after starting drug treatment')"]Blood pressure
Body mass index
Fasting glucose level
Fasting lipid levels
Lifestyle counseling[/conditional]
[html]<hr>[/html][checkbox memo="display/hide footnotes" name="footnotes" value=""][conditional field="footnotes" condition="(footnotes).is('')"][html]
reference:  <a href="http://www.ncbi.nlm.nih.gov/pubmed/21804146" target="_blank">De Hert M, Vancampfort D, Correll CU, Mercken V, Peuskens J, Sweers K, van Winkel R, Mitchell AJ. Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry. 2011 Aug;199(2):99-105.</a>, <a href="http://www.nimh.nih.gov/health/publications/mental-health-medications/index.shtml#pub4" target="_blank">NIMH - Antipsychotic medications</a>
posted by:  Mark Morgan, M.D.
post/review dates:  January 11, 2015; September 7, 2015
revision history: <a href="https://github.com/soapnote/SOAPnote-site/tree/master/generator/txt/mental-health/atypical-antipsychotic-monitor.txt" target="_blank">www.github.com/soapnote/SOAPnote-site/tree/master/generator/txt/mental-health/atypical-antipsychotic-monitor.txt</a>
markup link:  <a href="http://www.soapnote.org/generator/txt/mental-health/atypical-antipsychotic-monitor.txt" target="_blank">www.soapnote.org/generator/txt/mental-health/atypical-antipsychotic-monitor.txt</a>[/html][/conditional]